Works by Razavi, Pedram


Results: 37
    1

    Genomic landscape of breast cancer in elderly patients.

    Published in:
    NPJ Breast Cancer, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41523-025-00781-4
    By:
    • Selenica, Pier;
    • Dopeso, Higinio;
    • Repetto, Matteo;
    • Basili, Thais;
    • Gazzo, Andrea M.;
    • Schwartz, Christopher J.;
    • Derakhshan, Fatemeh;
    • Marra, Antonio;
    • Ferrando, Lorenzo;
    • Beets-Tan, Regina G. H.;
    • Wen, Y. H.;
    • Ross, Dara S.;
    • Brogi, Edi;
    • Zhang, Hong;
    • Norton, Larry;
    • Chandarlapaty, Sarat;
    • Razavi, Pedram;
    • Mandelker, Diana;
    • Reis-Fiho, Jorge S.;
    • Weigelt, Britta
    Publication type:
    Article
    2

    Trends in childhood brain tumor incidence, 1973-2009.

    Published in:
    Journal of Neuro-Oncology, 2013, v. 115, n. 2, p. 153, doi. 10.1007/s11060-013-1212-5
    By:
    • McKean-Cowdin, Roberta;
    • Razavi, Pedram;
    • Barrington-Trimis, Jessica;
    • Baldwin, Rachel;
    • Asgharzadeh, Shahab;
    • Cockburn, Myles;
    • Tihan, Tarik;
    • Preston-Martin, Susan
    Publication type:
    Article
    3

    Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 1, p. e2034045, doi. 10.1001/jamanetworkopen.2020.34045
    By:
    • Sutton, Elizabeth J.;
    • Braunstein, Lior Z.;
    • El-Tamer, Mahmoud B.;
    • Brogi, Edi;
    • Hughes, Mary;
    • Bryce, Yolanda;
    • Gluskin, Jill S.;
    • Powell, Simon;
    • Woosley, Alyssa;
    • Tadros, Audree;
    • Sevilimedu, Varadan;
    • Martinez, Danny F.;
    • Toni, Larowin;
    • Smelianskaia, Olga;
    • Nyman, C. Gregory;
    • Razavi, Pedram;
    • Norton, Larry;
    • Fung, Maggie M.;
    • Sedorovich, James D.;
    • Sacchini, Virgilio
    Publication type:
    Article
    4

    Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer.

    Published in:
    JAMA Network Open, 2020, v. 3, n. 10, p. e2018790, doi. 10.1001/jamanetworkopen.2020.18790
    By:
    • Bitencourt, Almir;
    • Rossi Saccarelli, Carolina;
    • Morris, Elizabeth A.;
    • Flynn, Jessica;
    • Zhang, Zhigang;
    • Khan, Atif;
    • Gillespie, Erin;
    • Cahlon, Oren;
    • Mueller, Boris;
    • Cuaron, John J.;
    • McCormick, Beryl;
    • Powell, Simon N.;
    • Plitas, George;
    • Razavi, Pedram;
    • Pinker, Katja;
    • Riedl, Christopher C.;
    • Sutton, Elizabeth J.;
    • Braunstein, Lior Z.
    Publication type:
    Article
    5
    6
    7

    HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27093-y
    By:
    • Smith, Alison E.;
    • Ferraro, Emanuela;
    • Safonov, Anton;
    • Morales, Cristina Bernado;
    • Lahuerta, Enrique J. Arenas;
    • Li, Qing;
    • Kulick, Amanda;
    • Ross, Dara;
    • Solit, David B.;
    • de Stanchina, Elisa;
    • Reis-Filho, Jorge;
    • Rosen, Neal;
    • Arribas, Joaquín;
    • Razavi, Pedram;
    • Chandarlapaty, Sarat
    Publication type:
    Article
    8
    9
    10
    11

    Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 801, p. 1, doi. 10.1126/scitranslmed.adk7786
    By:
    • Cai, Yanyan;
    • Zhao, Peihua;
    • Wu, Fan;
    • Zhao, Huiyong;
    • Shao, Hong;
    • Marra, Antonio;
    • Patel, Payal;
    • O'Connell, Elizabeth;
    • Fink, Emma;
    • Miele, Matthew M.;
    • Li, Zhuoning;
    • De Stanchina, Elisa;
    • Cocco, Emiliano;
    • Razavi, Pedram;
    • Toska, Eneda;
    • Fanning, Sean W.;
    • Xu, Guotai;
    • Sablina, Anna A.;
    • Scaltriti, Maurizio;
    • Chandarlapaty, Sarat
    Publication type:
    Article
    12
    13
    14
    15

    Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00380-7
    By:
    • Ferraro, Emanuela;
    • Singh, Jasmeet;
    • Patil, Sujata;
    • Razavi, Pedram;
    • Modi, Shanu;
    • Chandarlapaty, Sarat;
    • Barrio, Andrea V.;
    • Malani, Rachna;
    • Mellinghoff, Ingo K.;
    • Boire, Adrienne;
    • Wen, Hannah Y.;
    • Brogi, Edi;
    • Seidman, Andrew D.;
    • Norton, Larry;
    • Robson, Mark E.;
    • Dang, Chau T.
    Publication type:
    Article
    16

    Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40793-x
    By:
    • Skakodub, Anna;
    • Walch, Henry;
    • Tringale, Kathryn R.;
    • Eichholz, Jordan;
    • Imber, Brandon S.;
    • Vasudevan, Harish N.;
    • Li, Bob T.;
    • Moss, Nelson S.;
    • Hei Yu, Kenny Kwok;
    • Mueller, Boris A.;
    • Powell, Simon;
    • Razavi, Pedram;
    • Yu, Helena A.;
    • Reis-Filho, Jorge S.;
    • Gomez, Daniel;
    • Schultz, Nikolaus;
    • Pike, Luke R. G.
    Publication type:
    Article
    17

    Nanowire transistors without junctions.

    Published in:
    Nature Nanotechnology, 2010, v. 5, n. 3, p. 225, doi. 10.1038/nnano.2010.15
    By:
    • Colinge, Jean-Pierre;
    • Lee, Chi-Woo;
    • Afzalian, Aryan;
    • Akhavan, Nima Dehdashti;
    • Yan, Ran;
    • Ferain, Isabelle;
    • Razavi, Pedram;
    • O'Neill, Brendan;
    • Blake, Alan;
    • White, Mary;
    • Kelleher, Anne-Marie;
    • McCarthy, Brendan;
    • Murphy, Richard
    Publication type:
    Article
    18
    19

    A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.

    Published in:
    Investigational New Drugs, 2017, v. 35, n. 6, p. 742, doi. 10.1007/s10637-017-0445-0
    By:
    • Smyth, Lillian;
    • Monson, Kelsey;
    • Jhaveri, Komal;
    • Drilon, Alexander;
    • Li, Bob;
    • Abida, Wassim;
    • Iyer, Gopa;
    • Gerecitano, John;
    • Gounder, Mrinal;
    • Harding, James;
    • Voss, Martin;
    • Makker, Vicky;
    • Ho, Alan;
    • Razavi, Pedram;
    • Iasonos, Alexia;
    • Bialer, Philip;
    • Lacouture, Mario;
    • Teitcher, Jerrold;
    • Erinjeri, Joseph;
    • Katabi, Nora
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).

    Published in:
    Science Signaling, 2018, v. 11, n. 551, p. 1, doi. 10.1126/scisignal.aat9773
    By:
    • Cocco, Emiliano;
    • Javier Carmona, F.;
    • Razavi, Pedram;
    • Won, Helen H.;
    • Cai, Yanyan;
    • Rossi, Valentina;
    • Chan, Carmen;
    • Cownie, James;
    • Soong, Joanne;
    • Toska, Eneda;
    • Shifman, Sophie G.;
    • Sarotto, Ivana;
    • Savas, Peter;
    • Wick, Michael J.;
    • Papadopoulos, Kyriakos P.;
    • Moriarty, Alyssa;
    • Cutler, Richard E.;
    • Avogadri-Connors, Francesca;
    • Lalani, Alshad S.;
    • Bryce, Richard P.
    Publication type:
    Article
    28

    Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.

    Published in:
    Breast Cancer Research & Treatment, 2022, v. 195, n. 3, p. 341, doi. 10.1007/s10549-022-06669-2
    By:
    • Walsh, Elaine M.;
    • Gucalp, Ayca;
    • Patil, Sujata;
    • Edelweiss, Marcia;
    • Ross, Dara S.;
    • Razavi, Pedram;
    • Modi, Shanu;
    • Iyengar, Neil M.;
    • Sanford, Rachel;
    • Troso-Sandoval, Tiffany;
    • Gorsky, Mila;
    • Bromberg, Jacqueline;
    • Drullinsky, Pamela;
    • Lake, Diana;
    • Wong, Serena;
    • DeFusco, Patricia Ann;
    • Lamparella, Nicholas;
    • Gupta, Ranja;
    • Tabassum, Tasmila;
    • Boyle, Leigh Ann
    Publication type:
    Article
    29

    Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2020, v. 183, n. 1, p. 227, doi. 10.1007/s10549-020-05726-y
    By:
    • Wang, Diana G.;
    • Barrios, Dulce M.;
    • Blinder, Victoria S.;
    • Bromberg, Jacqueline F.;
    • Drullinsky, Pamela R.;
    • Funt, Samuel A.;
    • Jhaveri, Komal L.;
    • Lake, Diana E.;
    • Lyons, Tomas;
    • Modi, Shanu;
    • Razavi, Pedram;
    • Sidel, Michelle;
    • Traina, Tiffany A.;
    • Vahdat, Linda T.;
    • Lacouture, Mario E.
    Publication type:
    Article
    30

    TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.

    Published in:
    NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00250-8
    By:
    • da Silva, Edaise M.;
    • Selenica, Pier;
    • Vahdatinia, Mahsa;
    • Pareja, Fresia;
    • Da Cruz Paula, Arnaud;
    • Ferrando, Lorenzo;
    • Gazzo, Andrea M.;
    • Dopeso, Higinio;
    • Ross, Dara S.;
    • Bakhteri, Ariya;
    • Riaz, Nadeem;
    • Chandarlapaty, Sarat;
    • Razavi, Pedram;
    • Norton, Larry;
    • Wen, Hannah Y.;
    • Brogi, Edi;
    • Weigelt, Britta;
    • Zhang, Hong;
    • Reis-Filho, Jorge S.
    Publication type:
    Article
    31

    The genomic landscape of metastatic histologic special types of invasive breast cancer.

    Published in:
    NPJ Breast Cancer, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41523-020-00195-4
    By:
    • Pareja, Fresia;
    • Ferrando, Lorenzo;
    • Lee, Simon S. K.;
    • Beca, Francisco;
    • Selenica, Pier;
    • Brown, David N.;
    • Farmanbar, Amir;
    • Da Cruz Paula, Arnaud;
    • Vahdatinia, Mahsa;
    • Zhang, Hong;
    • Zoppoli, Gabriele;
    • Wen, Hannah Y.;
    • Brogi, Edi;
    • Robson, Mark E.;
    • Razavi, Pedram;
    • Chandarlapaty, Sarat;
    • Weigelt, Britta;
    • Reis-Filho, Jorge S.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37